Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pelvic Pain D017699 7 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Leukostasis D018921 1 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Endotoxemia D019446 27 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Venous Thrombosis D020246 11 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Migraine without Aura D020326 1 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Stroke D020521 32 associated lipids
Fetal Weight D020567 12 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Coronary Stenosis D023921 6 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Hyperuricemia D033461 4 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Atherosclerosis D050197 85 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Mucositis D052016 7 associated lipids
Acute Lung Injury D055371 33 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Hattermann K et al. The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis. 2007 FASEB J. pmid:17264163
De Vriese C et al. Ghrelin interacts with human plasma lipoproteins. 2007 Endocrinology pmid:17289852
Doublier S et al. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase. 2007 Clin. Cancer Res. pmid:17908960
Shimada T et al. Cross-regulation of cortisol secretion by adrenocorticotropin and platelet-activating factor in perfused guinea pig adrenals. 2007 J. Endocrinol. pmid:17911394
Whitehead SN et al. Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry. 2007 Anal. Chem. pmid:17949058
Bixby CE et al. Role of platelet-activating factor in pulmonary vascular remodeling associated with chronic high altitude hypoxia in ovine fetal lambs. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17951313
Liu WC et al. Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist. 2007 Neurosci Bull pmid:17952135
Wu B et al. [Effects of bificobacterium longum on neonatal rat model of necrotizing enterocolitis and roles of platelet-activating factor and tumor necrosis factor-alpha]. 2007 Zhonghua Er Ke Za Zhi pmid:17953818
Owen JS et al. Platelet-activating factor. 2007 Meth. Enzymol. pmid:17954244
Ying-fang S et al. Effect of platelet-activating factor on cell proliferation & NF-kappaB activation in airway smooth muscle cells in rats. 2007 Indian J. Med. Res. pmid:17932440
Guerra CT et al. Effect of chronic hepatitis C virus infection on inflammatory lipid mediators. 2007 Dig Liver Dis pmid:17936229
Kawano Y et al. The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a). 2007 Am. J. Reprod. Immunol. pmid:17922696
Ebihara S et al. A simple preparation method for mouse eosinophils and their responses to anti-allergic drugs. 2007 Inflamm. Res. pmid:17406808
Ferreira MA et al. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). 2007 Life Sci. pmid:17588613
Xia SH et al. Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021. 2007 World J. Gastroenterol. pmid:17589953
Tosaki T et al. Enhancement of acetyl-CoA: 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity by hydrogen peroxide. 2007 Biol. Pharm. Bull. pmid:17268064
Zhang X et al. Down-regulation of platelet-activating factor receptor gene expression during focal reversible cerebral ischemia in rats. 2007 Neurochem. Res. pmid:17268849
Sandford RM et al. The genetic basis of abdominal aortic aneurysms: a review. 2007 Eur J Vasc Endovasc Surg pmid:17276705
Slomiany BL and Slomiany A Interference by leptin with Helicobacter pylori lipopolysaccharide-induced cytosolic phospholipase A2 activation in gastric mucosal cells. 2007 J. Physiol. Pharmacol. pmid:17440231
Ullrich SE Sunlight and skin cancer: lessons from the immune system. 2007 Mol. Carcinog. pmid:17443748
Richter M et al. Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17448648
Finnegan EM et al. Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:17483236
Cattaneo M et al. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. 2007 Haematologica pmid:17488697
Kälvegren H et al. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors. 2007 Eur. J. Pharmacol. pmid:17459368
Taheri F and Bazan HE Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells. 2007 Invest. Ophthalmol. Vis. Sci. pmid:17460244
Dinubile MJ Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin". 2007 Am. J. Physiol., Cell Physiol. pmid:17428843
Zhao W et al. [Effect of PAF on the expression of PACAP mRNA in the granulosa cells of rat ovary]. 2007 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21180114
Xavier RG et al. Enhanced platelet aggregation and activation under conditions of hypothermia. 2007 Thromb. Haemost. pmid:18064324
Dunkel B et al. Platelet activation in ponies with airway inflammation. 2007 Equine Vet. J. pmid:18065316
Lu SM et al. The phospholipid mediator platelet-activating factor mediates striatal synaptic facilitation. 2007 J Neuroimmune Pharmacol pmid:18040844
Rockel N et al. The osmolyte taurine protects against ultraviolet B radiation-induced immunosuppression. 2007 J. Immunol. pmid:17785795
Li J et al. Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity. 2007 Int. J. Neuropsychopharmacol. pmid:16426477
Shi W et al. [Study on composing mechanism by effect of disassembled compositions of Yiqi Huoxue decoction on platelet aggregation of health adults]. 2007 Zhongguo Zhong Yao Za Zhi pmid:18309677
Ibe BO et al. Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle. 2007 J. Pharmacol. Exp. Ther. pmid:17085546
Saluk-Juszczak J et al. The effect of lipopolysaccharide from Proteus mirabilis on the level of the stable end metabolic products of nitric oxide in blood platelets. 2007 Curr. Microbiol. pmid:17160361
Huang YH et al. Suppression effect of seminal vesicle autoantigen on platelet-activating factor-induced mouse sperm capacitation. 2007 J. Cell. Biochem. pmid:17131380
Osborn TM et al. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. 2007 Am. J. Physiol., Cell Physiol. pmid:17135294
Bathgate R et al. Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters. 2007 Theriogenology pmid:17157372
Hammond A et al. Platelets in equine recurrent airway obstruction. 2007 Res. Vet. Sci. pmid:17107696
Vinores SA et al. TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage. 2007 J. Neuroimmunol. pmid:17107717
Brkovic A and Sirois MG Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis. 2007 J. Cell. Biochem. pmid:17115409
Choi JH et al. Impairment of p38 MAPK-mediated cytosolic phospholipase A2 activation in the kidneys is associated with pathogenicity of Candida albicans. 2007 Immunology pmid:17054728
El Behi M et al. Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs. 2007 J. Neuroimmunol. pmid:17097744
Blanchet MR et al. Modulation of eosinophil activation in vitro by a nicotinic receptor agonist. 2007 J. Leukoc. Biol. pmid:17289799
Shindou H et al. A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase. 2007 J. Biol. Chem. pmid:17182612
Ko HM et al. Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis. 2007 Int. J. Cancer pmid:17187368
Park EJ et al. Dietary ganglioside inhibits acute inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of Escherichia coli lipopolysaccharide. 2007 Shock pmid:17510604
Young RE et al. Role of neutrophil elastase in LTB4-induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice. 2007 Br. J. Pharmacol. pmid:17471175
Steel HC et al. Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4. 2007 Clin. Exp. Immunol. pmid:17683509
Eckert RE and Jones SL Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant. 2007 J. Leukoc. Biol. pmid:17684042